SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-24-000125
Filing Date
2024-07-12
Accepted
2024-07-12 16:30:14
Documents
13
Period of Report
2024-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20240711.htm   iXBRL 8-K 25427
  Complete submission text file 0001367644-24-000125.txt   151114

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20240711.xsd EX-101.SCH 1967
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20240711_lab.xml EX-101.LAB 22804
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20240711_pre.xml EX-101.PRE 13102
15 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20240711_htm.xml XML 2819
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 241114851
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)